Abstract:BACKGROUND:The constitutively existed tumor stem cells in the microenvironment of bone marrow changed the characteristics of marrow stromal cells and extracellular matrix,and involved in the malignancy of hematopoietic stem cells.OBJECTIVE:To investigate the matrix metalloproteinase-9(MMP-9) expression in bone marrow mesenchymal stem cells(BMSCs) in chronic myelocytic leukemia patients and its adhesive effects on hematopoietic stem cells.DESIGN,TIME AND SETTING:The cytology in vitro controlled study was performed at the Basic College,Peking Union Medical College from September 2007 and February 2008.MATERIALS:Bone marrow samples,which were collected from 4 chronic myelocytic leukemia patients and 4 healthy volunteers,were obtained from the Department of Hematology,the 309 Hospital of Chinese PLA.Umbilical cord blood was provided by Beijing Umbilical Cord Blood Hematopoietic Stem Cell Pool.293T cells were presented by Professor Kong from Nankai University.METHODS:Bone marrow was harvested from healthy volunteers and chronic myelocytic leukemia patients.BMSCs were collected by the Ficoll method in vitro.Umbilical cord blood was separately packed,centrifuged to remove the supernatant.The intermedium was taken.Umbilical cord blood mononuclear cells were isolated and obtained by the same method.BMSCs in the logarithmic phase were incubated in a 96-well culture plate at 1×107/L per well.When 100% cells were confluent,umbilical cord blood mononuclear cells were incubated in the same culture plate at 1×105 per well for 1 hour.Following non-adherent cells were removed,adherent rate was calculated.At the second passage,BMSCs were harvested.Mass concentration of soluble intercellular adhesion molecule-1 in the supernatant was measured by enzyme linked immunosorbent assay.MPP-9 siRNA interference vector was constructed.293T cells were transfected and encased by the liposome method.BMSCs were transfected following virus amplification.MAIN OUTCOME MEASURES:Five indexes were compared between healthy donors and chronic myelocytic leukemia patients.Three indexes were compared among chronic myelocytic leukemia patients before and after virus transfection.RESULTS:Compared with the healthy donors,MMP-9 mRNA and protein levels in BMSCs were significantly increased in the chronic myelocytic leukemia patients,and no significant differences were detected in intercellular adhesion molecule-1,and mass concentration of soluble intercellular adhesion molecule-1 was significantly increased in the supernatant(P < 0.05).Adherent rate of umbilical cord blood mononuclear cells were significant decreased(P < 0.05).Compared with the non-transfection BMSCs,MMP-9 mRNA expression was significant reduced following virus transfection,and intercellular adhesion molecule-1 protein expression was not affected,and the adherent rate of umbilical cord blood mononuclear cells was significantly increased(P < 0.05).CONCLUSION:The action mechanism of MMP-9-splited intercellular adhesion molecule-1 exists in BMSCs from chronic myelocytic leukemia patients.It is hypothesized that free soluble intercellular adhesion molecule-1 blocks the binding site of LFA-1,and finally affects the adherence of BMSCs on hematopoietic stem cells.

Effects of human bone morphogenetic protein 9 on migration and apoptosis of human breast cancer cells in simulated bone microenvironment in vitro

Effects of BMP9 over-expression on proliferation and migration of human breast cancer MDA-MB-231 cells in simulated breast adipose microenvironment in vitro and its possible mechanism

Biological Roles of Human Bone Morphogenetic Protein 9 in the Bone Microenvironment of Human Breast Cancer MDA-MB-231 Cells.

Bone Morphogenetic Protein 9 Regulates the Cross-Talk Between Breast Cancer Cells and Bone Marrow Mesenchymal Stem Cells

BMP9 Regulates Cross-Talk Between Breast Cancer Cells and Bone Marrow-Derived Mesenchymal Stem Cells.

BMP9 Inhibits Proliferation and Metastasis of HER2-positive SK-BR-3 Breast Cancer Cells Through ERK1/2 and PI3K/AKT Pathways.

Bone Morphogenetic Protein 9 Overexpression Reduces Osteosarcoma Cell Migration and Invasion

Construction of Recombinant Adenovirus Vector Interfering the Expression of Human BMP9 and Promoting the Proliferation of Breast Cancer SK-BR-3 Cells

Effects of Breast Cancer Stromal Cells on Expression of Wnt1,Notch1 and Β-Catenin and Migration of MCF-7 Cells

BMP9 Promotes Autophagy and Inhibits Migration and Invasion in Breast Cancer Cells Through the C-Myc/snhg3/mtor Signaling Axis.

Bone morphogenetic protein 9 enhances osteogenic and angiogenic responses of human amniotic mesenchymal stem cells cocultured with umbilical vein endothelial cells through the PI3K/AKT/m-TOR signaling pathway

Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4

Matrix metalloproteinase-9 expression in bone marrow mesenchemyl stem cells of chronic myeloid leukemia patients and its effects on hematopoietic stem cell adherence

Role of cAMP-PKA-CREB signal pathway in regulation of osteogenic differentiation of murine mesenchymal stem cells by bone morphogenetic protein 9

Bone Morphogenetic Protein 10 (Bmp-10) Inhibits Growth of Breast Cancer Cells and Correlates with Poor Prognosis

Effect of Bone Marrow Mesenchymal Stem Cells on MHCC97-H Cells after Transforming Growth Factor Beta1 and Osteopontin Gene Interference

Effect of a Bone Morphogenetic Protein-2-derived peptide on the expression of tumor marker ZNF217 in osteoblasts and MCF-7 cells

Bone Sialoprotein Promotes Tumor Cell Migration in Both In Vitro and In Vivo Models

The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation

Overexpression of Mir-155 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells C3H10T1/2 Induced by BMP9

Effects of Human Bone Morphogenetic Protein- 7 Gene on Bone Marrow Stromal Cell in Vitro